Basel, Switzerland

Michael Block

This inventor holds 1 USPTO granted patent. Top assignees: Bayer Consumer Care Ag, Emerald Lake Safety LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Block. Retrieved from https://idiyas.com/inventor/michael-block-qb24vgrg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Block - Innovator in Treatment Methods

Introduction

Michael Block is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of vasomotor symptoms. His innovative approach has led to the development of a unique patent that addresses the needs of female patients.

Latest Patents

Michael Block holds 1 patent for his work titled "Methods of treatment with elinzanetant." This patent focuses on methods for treating vasomotor symptoms in female subjects by administering a therapeutically effective amount of elinzanetant or a pharmaceutically acceptable salt or deuterated form. The treatment is designed to be used in conjunction with a moderate CYP3A4 inhibitor, showcasing a thoughtful approach to patient care.

Career Highlights

Throughout his career, Michael Block has worked with reputable companies, including Emerald Lake Safety LLC and Bayer Consumer Care AG. His experience in these organizations has allowed him to refine his skills and contribute to advancements in healthcare.

Collaborations

Michael has collaborated with notable professionals in his field, including Alexander Solms and Stefan Willmann. These partnerships have further enriched his work and expanded the impact of his innovations.

Conclusion

Michael Block's contributions to the field of treatment methods highlight his dedication to improving patient outcomes. His innovative patent and collaborative efforts reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…